Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice
- 1 June 1989
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 27 (3-4) , 378-379
- https://doi.org/10.1007/bf01972827
Abstract
The type II collagen induced arthritis model was used to evaluate the efficacy of tissue inhibitor of metalloproteases (TIMP) in suppressing the disease in DBA/1 mice. Treatment began following the first clinical manifestations of the disease state. Clinical observations, histological and radiographic findings show a decreased incidence of joint erosion in the treated population relative to the controls. It is concluded that systemic administration of recombinant human TIMP suppresses the pathology of type II collagen induced arthritis.Keywords
This publication has 4 references indexed in Scilit:
- Collagen autoimmunity and arthritisThe FASEB Journal, 1988
- Primary structure and cDNA cloning of human fibroblast collagenase inhibitor.Proceedings of the National Academy of Sciences, 1986
- Collagen Autoimmune ArthritisAnnual Review of Immunology, 1984
- Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization.Journal of Biological Chemistry, 1983